Sort by 
Alira Health report projects medtech CDMO market to reach $143.6b by 2030
A new report by US-based global healthcare consulting firm Alira Health projects the medtech contract development and manufacturing organisation market will reach $143.6b by 2030, driven by pharma-medtech convergence and rising demand for integrated capabilities.
Eli Lilly agrees to acquire Centessa Pharmaceuticals in $6.3 billion neuroscience deal
US pharmaceutical giant Eli Lilly has agreed to acquire London-based clinical-stage company Centessa Pharmaceuticals in a deal valued at up to $47.00 (€43.50) per share, targeting treatments for excessive daytime sleepiness and sleep-wake disorders.
Eirgen Pharma secures HPRA approval for new Waterford manufacturing facility
Waterford-based Eirgen Pharma has received full HPRA approval for its newly constructed manufacturing facility at the IDA Waterford Business Park, authorising the site to produce investigational and commercial pharmaceutical products.
John Paul Construction completes Dexcom CGM manufacturing facility in Athenry
Irish contractor John Paul Construction has completed work on a Dexcom medical device manufacturing facility in Athenry, Ireland, marking the San Diego-based CGM developer's first production site outside the United States.
West Pharmaceutical Services opens expanded Dublin facility to meet injectable therapy demand
West Pharmaceutical Services has opened a 165,000 sq ft expansion at its Damastown, Dublin site, strengthening its pharmaceutical contract manufacturing and drug delivery capabilities to meet rising global demand for injectable therapies.
SGS Scientific Insourcing builds scalable GxP capability for life science teams
SGS Scientific Insourcing delivers flexible GxP resourcing solutions that embed proven scientific expertise directly into client organisations, strengthening capability without disrupting operational continuity.
MGI Tech collaborates with NUS Pharmacy on multi-omics laboratory
China-based MGI Tech and National University of Singapore's Department of Pharmacy and Pharmaceutical Sciences have announced collaboration on a multi-omics laboratory. The partnership advances genomic sequencing and drug discovery capabilities.
Merck acquires Terns Pharmaceuticals for $6.7 billion to expand hematology portfolio
United States-based Merck has agreed to acquire Terns Pharmaceuticals for $6.7 billion (€5.7 billion), gaining TERN-701, an investigational oral therapy for chronic myeloid leukemia. The transaction strengthens Merck's pharmaceutical manufacturing excellence capabilities in hematology.
Amgen invests $407 million in Dun Laoghaire manufacturing expansion
United States-based Amgen has invested $407 million (€353 million) in capital expenditure at its Dun Laoghaire manufacturing facility over two years. The investment strengthens Ireland's pharmaceutical manufacturing excellence capabilities and supports workforce expansion plans.
Steris emerges as preferred bidder for Cardinal Health Tullamore facility
United States-based Steris is the preferred bidder to acquire Cardinal Health's Tullamore facility closing in April. The transaction preserves pharmaceutical manufacturing excellence operations in County Offaly and is expected to create new positions.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
